RSS Feed For (NY:DGX)

QUEST DIAGNOSTICS, Inc. (NY:DGX)

58.15 +0.02 (0.03%)
QUEST DIAGNOSTICS, Inc. (NY:DGX) Delayed :
Previous Close $58.13    52 Week High $59.57 
Open $58.06    52 Week Low $40.00 
Day High $58.47    P/E 15.38 
Day Low $57.95    EPS $3.78 
Volume 1,331,928       
More DGX Info: Chart SEC Filings Profile Historical Options

Quest Diagnostics Inc. Summary

Quest Diagnostics Incorporated provides diagnostic testing, information, and services for healthcare industry in the United States. The company offers routine tests, including blood and cholesterol level, blood chemistries, complete blood cell counts, pregnancy, substance-abuse tests, and asthma and allergy ...more

Executives

Surya N. Mohapatra - Chairman, CEO

Links

http://www.questdiagnostics.com,

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
CAT 6 CMA 5
RF 5 UNH 5
UTX 4 STT 4
DD 4 COH 4
JEF 4 MRK 4
WU 4 ZION 4
View All Friends, Peers and Foes

StreetInsider Reports on DGX by Category

Comments on recent DGX articles

Leah
on Oct 5, 2009
at 05:13 PM
Quest doesnt deal in Pharmaceuticals! Quest doesnt deal in Pharmaceuticals! Who wrote this article? & Surya the CEO actually approved this as accurate information?! Quest Diagnostics is a major worldwide Medical Laboratory Testing Corporation, they have NOTHING to do with pharmaceuticals & Care360 has to do with ordering laboratory tests on people with various health problems. Wow, this is really bad!
Article: Quest Diagnostics Empowers the Nation's Physicians to Immediately Embrace ePrescribing
Harry L
on Jun 11, 2008
at 06:18 PM
Why buy? This company hasn't gone a damn thing profitable since the morons running the company decided that losing 25% of their business (i.e. United HealthCare) in Oct. 2006 was a good thing. The stock has bounced from about where it is now up to around $56 a share. I don't have any issues with the profitability of the company itself but I certainly have issues with the way the company is being run. I dumped my Quest stock a little less than a year ago and I see no reason to begin buying it again. I predict another year of laguishing around $50 a share. No better and maybe a bit worse. Better to buy something that has potential to grow significantly such as Corning (GLW) or Covance(CVD). I'm making money with them at least.
Article: Merrill Lynch Upgrades Quest Diagnostics (DGX) to Buy

Comments on DGX


No comments are currently available.